search button

High glucose reduces hepatic glycogenesis by suppression of microRNA‑152

  • Authors:
    • Xiaoyun Zhao
    • Yonggang Lu
    • Fenghong Wang
    • Lin Dou
    • Lilin Wang
    • Jun Guo
    • Jian Li

  • View Affiliations

  • Published online on: July 28, 2014     https://doi.org/10.3892/mmr.2014.2426
  • Pages: 2073-2078
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MicroRNAs (miRNAs) are a class of non‑coding 18‑25-nucleotide endogenous RNA molecules. miRNAs act as specific gene silencers to regulate target gene expression at the posttranscriptional level, by base pairing to the 3'‑untranslated region of the target mRNA. miR‑152 is an miRNA that was originally identified in cancer cells, and was shown to be able to modulate the expression of specific oncogenes and tumor suppressor genes, leading to enhanced carcinoma growth. However, little is known regarding the role of miR‑152 in the regulation of hepatic insulin resistance and glucose metabolism. In the present study, it was identified that the activation of AKT and glycogen synthase kinase 3 (GSK‑3), and the expression levels of glycogen, were reduced in mouse NCTC 1469 hepatocytes and mouse primary hepatocytes, following exposure to 25 mM glucose for 48 h. Furthermore, it was demonstrated that high glucose levels suppressed the expression of miR‑152 in hepatocytes. In order to further assess the effects of miR‑152 on the glucose‑induced reduction of glycogen synthesis and activation of AKT and GSK, miR‑152 mimic and inhibitor were transfected into the NCTC 1469 cells, respectively. The transfection of the miR‑152 inhibitor resulted in reduced expression of glycogen, accompanied by impaired phosphorylation of AKT and GSK in the NCTC 1469 cells treated with or without glucose. Conversely, upregulation of miR‑152 by transfection of an miR‑152 mimic reversed the glucose‑induced decrease in glycogen synthesis and reduced AKT and GSK phosphorylation in hepatocytes. This indicated that miR‑152 could modulate the AKT/GSK pathway and glycogen synthesis. In conclusion, to the best of our knowledge, this study was the first to indicate that high glucose impaired the activation of the AKT/GSK pathway and the synthesis of glycogen in mouse hepatocytes, in part through the downregulation of miR‑152.
View Figures
View References

Related Articles

Journal Cover

October 2014
Volume 10 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
  • CiteScore: 6.9
  • CiteScore Rank: Q2: #98/328 Biochemistry, Genetics and Molecular Biology
  • Source Normalized Impact per Paper (SNIP): 0.721
  • SCImago Journal Rank (SJR): 0.65
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao X, Lu Y, Wang F, Dou L, Wang L, Guo J and Li J: High glucose reduces hepatic glycogenesis by suppression of microRNA‑152. Mol Med Rep 10: 2073-2078, 2014
APA
Zhao, X., Lu, Y., Wang, F., Dou, L., Wang, L., Guo, J., & Li, J. (2014). High glucose reduces hepatic glycogenesis by suppression of microRNA‑152. Molecular Medicine Reports, 10, 2073-2078. https://doi.org/10.3892/mmr.2014.2426
MLA
Zhao, X., Lu, Y., Wang, F., Dou, L., Wang, L., Guo, J., Li, J."High glucose reduces hepatic glycogenesis by suppression of microRNA‑152". Molecular Medicine Reports 10.4 (2014): 2073-2078.
Chicago
Zhao, X., Lu, Y., Wang, F., Dou, L., Wang, L., Guo, J., Li, J."High glucose reduces hepatic glycogenesis by suppression of microRNA‑152". Molecular Medicine Reports 10, no. 4 (2014): 2073-2078. https://doi.org/10.3892/mmr.2014.2426